DMT Is Produced Inside Your Brain. What Does That Actually Mean?

Your brain makes DMT. This is not a conspiracy theory or New Age speculation. It is a documented biological fact.

The question scientists haven't answered is why.

What is DMT?

Dimethyltryptamine is a naturally occurring tryptamine. Structurally, it is closely related to serotonin and melatonin — it shares the same tryptamine backbone that forms the entire family.

At sufficient doses, inhaled DMT produces one of the most intense altered states of consciousness known to science. Effects onset within seconds, peak within two to five minutes, and resolve within fifteen minutes. Within that window, users consistently report: complete dissolution of ordinary reality, encounters with geometric visual phenomena of extraordinary complexity, and apparent contact with non-human entities or intelligences.

The reports of entity contact are one of the most documented and methodologically puzzling aspects of DMT research. In surveys of thousands of DMT users, a substantial majority report encounters with beings they describe as autonomous, apparently real, and communicative. These reports are consistent across users with no prior contact with each other, across cultures and backgrounds.

Where in the body is DMT produced?

The primary confirmed sites of DMT production in the human body are the lungs, brain tissue, and cerebrospinal fluid. The enzyme systems required to synthesize DMT — INMT and AADC — are present in neural tissue, and DMT itself has been measured in human blood and urine.

The pineal gland question requires careful handling. The popular claim that the pineal gland produces significant amounts of DMT during sleep or near-death experiences has not been confirmed in humans. It has been demonstrated in rats. The pineal gland does contain INMT, the key enzyme in DMT synthesis. But elevated DMT production from the pineal gland during specific states remains a hypothesis — an interesting one with some supporting evidence, but not confirmed.

What DMT does in the brain

DMT primarily binds to two receptor systems: 5-HT2A (the same serotonin receptor subtype targeted by psilocybin) and sigma-1 receptors, which are involved in neuroprotection, immune function, and stress response.

The 5-HT2A activity produces the hallucinogenic effects. The sigma-1 activity may be relevant to the compound's role in neuroprotection and in states like hypoxia — low-oxygen conditions, which are characteristic of near-death experiences.

The combination of these two receptor targets — one producing profound consciousness alteration, one potentially involved in cellular protection during physiological stress — is unusual. It suggests a compound that might serve multiple functions simultaneously.

The pineal gland question

Rick Strassman's work in the 1990s remains the foundational human study of DMT's effects. His hypothesis — that the pineal gland produces DMT during threshold states including dreaming, birth, death, and mystical experience — has shaped much of the popular discourse around endogenous DMT.

The hypothesis remains unconfirmed in humans specifically. What is confirmed: DMT is produced endogenously across multiple tissues, the pineal gland has the enzymatic machinery to produce it, and something is producing the DMT measured in human blood. The quantity and source during specific psychological states is not yet established.

DMT and near-death experiences

The phenomenological overlap between near-death experiences (NDEs) and DMT experiences is substantial and well-documented.

Both involve: apparent contact with non-human entities or presences, a sense of leaving the body, passage through a threshold, encounters with deceased individuals, and profound feelings of peace, love, or universal significance. The structural similarity is striking enough that Strassman proposed endogenous DMT release as the mechanism underlying NDEs.

The evidence for this hypothesis is circumstantial but coherent: DMT sigma-1 activity may confer neuroprotection under hypoxia, which would explain why the brain might upregulate DMT production when dying. Sigma-1 receptors are involved in cellular survival responses. A compound that both protects neural tissue and produces experiences of transcendent peace under dying conditions would have extraordinary adaptive value — or would be extraordinary design.

DMT and dreams

A related hypothesis: endogenous DMT may play a role in REM dream states.

During REM sleep, the brain produces vivid visual imagery, narrative experience, and encounters with seemingly autonomous characters. The phenomenology overlaps with lower-dose DMT experience. The pineal gland is most active during sleep. INMT — the DMT-synthesizing enzyme — shows circadian variation.

The evidence is suggestive rather than conclusive. But if endogenous DMT contributes to ordinary dream experience, it means DMT isn't just a psychedelic compound — it's a component of baseline human consciousness across every night of sleep.

The evolutionary question

Your brain produces the same molecule found in hundreds of plants across every continent — a molecule that, at sufficient doses, produces experiences of contact with non-human intelligence. The plants make it. Your brain makes it. Whatever DMT is for, it seems to be for something.

The evolutionary question is straightforward and unanswered: why would a brain produce one of the most powerful psychedelics known?

The candidates:

• Neuroprotection under stress (sigma-1 activity)
• Modulation of ordinary cognitive states (dream-related)
• Regulation of consciousness itself in some baseline way
• A function we haven't identified yet

What's missing from the evolutionary literature is a satisfying explanation for why DMT specifically — this compound, with this receptor profile, producing these specific experiences — was selected for endogenous production.

The Technospermia interpretation

The Psychospermia framework offers a specific answer to the evolutionary question.

If DMT is consciousness technology — designed to interface with nervous systems sufficiently complex to benefit from altered states — then having it pre-installed in the receiver is elegant engineering. You don't need the organism to consume a plant. The hardware comes pre-loaded with the interface software.

The plants are the external delivery mechanism. The endogenous production is the built-in access. The technology is distributed at both levels simultaneously — externally, via hundreds of plant species on every continent, and internally, via biosynthesis within every mammalian brain.

Under this frame, the question "why does your brain produce DMT?" has a simple answer: because that's what it was built to do.

Visit The Map for the full Technospermia theory, or read where did psychedelics come from for the broader pharmacological picture that includes DMT's place in the pattern.